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Biotechnology risk assessment in Australia: A
molecular perspective
Sharon Fox, Angus Morrison-Saunders and Dianne Katscherian*
Biotechnology, especially the development of genetically modiﬁed crops,
offers many potential economic, nutritional and environmental beneﬁts, but
equally many potential hazards and risks. Approval procedures for the
release of genetically modiﬁed organisms are established under the Gene
Technology Act 2000 (Cth). This article examines the methodology used to
identify potential molecular risks associated with the use of biotechnology in
food crop production. Evidence is presented which demonstrates the
potential for molecular hazards to occur and brings into question the ability of
risk assessment methods to identify these hazards. Despite appropriate
regulations being in place, it appears that current hazard analysis procedures
are not of sufficient sensitivity to ensure adequate protection for the
Australian people and environment.
INTRODUCTION
The use of biotechnology
1 in agriculture offers the promise of higher yielding, more nutritious crops,
with reduced reliance on pesticides and petrochemical fertilisers compared to traditional agricultural
practices. In light of the signiﬁcant environmental and health impacts that have resulted from current
agricultural practices, crops with these qualities are certainly desirable. However, while there are
enormous potential beneﬁts for society, there is an ongoing debate surrounding the use of
biotechnology for food crops. Consumers are anxious about both food and environmental safety, and a
range of social and ethical issues.
2 Despite attempts by various intergovernmental agencies and
governments to establish “rigorous and science based” assessment and approval systems, public
acceptance does not seem to be forthcoming. Public pressure has forced major food retailers in the
United States, United Kingdom and Asia to ban genetically modiﬁed (GM)
3 foods.
4 In Australia, a
recent commitment by chicken producers to remove GM grain from chicken feed indicates the
inﬂuence of public pressure here also.
5 Without full consumer acceptance, the potential of
biotechnology as an agricultural tool will not be fully realised.
The Gene Technology Act 2000 (Cth) (the Act) and the Gene Technology Regulations 2001 (Cth)
(the Regulations) established a mandatory, national enforceable licensing system for the use of gene
technology in Australia. Although the Act was heralded as the foundation of a comprehensive
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1“Biotechnology” is an umbrella term used to describe a number of experimental protocols that are used to transfer highly
modiﬁed genetic information (DNA) from one organism to another organism, eg from a bacteria to a plant or from a plant to a
plant. The terms biotechnology and gene technology are used interchangeably in this paper.
2Australia, Senate Community Affairs Reference Committee, A Cautionary Tale: Fish Don’t Lay Tomatoes (Australia, 2000)
available online at http://www.aph.gov.au/senate/committee/clac_ctte/completed_inquiries/1999-02/gene/report/report.pdf
(viewed 15 May 2006).
3Genetically modiﬁed (GM) crops are those that have been modiﬁed using biotechnology procedures.
4Hain M, Cocklin C and Gibbs D, “Regulating Biosciences: The Gene Technology Act 2000” (2002) 19 EPLJ 163 at 176.
5Bolt C, (2005) “Fears Force GM Chicken Feed from Chicken Menu”, The West Australian (11 February 2005), p 5.
(2006) 23 EPLJ 236 236 ©regulatory system,
6 it has resulted in very little real change with regard to the procedures which were
already being used to evaluate risks that may be associated with the release of genetically modiﬁed
organisms (GMOs). Reviews of the Act have highlighted several concerns. A discussion concentrating
of the research and development aspects of the Act, noted that Australian biotechnology policy is
“predicated on the assumption that the advantages in terms of economic competitiveness outweigh”
the ethical, consumer and environmental concerns that may be associated with the use of
biotechnology.
7 This view was reinforced in a paper that concluded the “comprehensive, independent
and accountable” regulatory process promised by the Australian government has not been
forthcoming.
8 The issue of environmental risk assessment under the Act has been addressed in a
review of the risk assessment methodology applied before the release of GM crops into the
environment.
9 It was concluded that “the theory and practice of risk assessment conducted by the
Regulator is ﬂawed”.
10 This argument was supported by an evaluation of the Risk Assessment and
Risk Management Plan (RARMP) for GM insect resistant cotton (Bollgard II) and GM insect resistant
and herbicide resistant cotton (Bollgard II/Roundup ready).
11 The review highlighted several
important issues, including that the scope of the environmental risk assessment was extremely narrow
and limited to “the potential for weediness” and “the potential for gene ﬂow to other organisms” and
does not address the broader long-term ecological effects of introducing these crops.
12
While previous authors have provided comprehensive reviews of the Act, its background, scope
and limitations, they have not addressed the molecular issues. This paper provides a discussion of the
molecular issues associated with using biotechnology to introduce genes into plant species. We relate
this to the approach of the regulatory authorities with regard to identifying hazards associated with the
use of biotechnology in food crops.
BIOTECHNOLOGY REGULATION: UNSUBSTANTIATED ASSUMPTIONS
The development of GM crops initially occurred more rapidly than the development of policies to
authorise their commercial release. In 1990, no statutes were in place to speciﬁcally regulate the
application of gene technologies. In response to community concerns, biotechnology companies felt
that an assessment process would help build consumer conﬁdence in GM food crops.
13 The challenge
confronting regulatory authorities was whether a need existed for these crops to undergo risk
assessments. Given that food crop species had long been grown and eaten without any evidence of
harm, if no known toxins are produced by the inserted gene/s (transgene), was there any need to
subject these crops to tests other than those normally carried out on new food plant varieties?
The issue was the subject of a joint meeting of the United Nations Food and Agriculture
Organisation (FAO) and the World Health Organisation (WHO). The document resulting from this
meeting, whilst recommending a new paradigm for safety evaluation, states that GM foods “will not
pose any new risks as compared with those that might be expected from existing food sources …
6Australia, House of Representatives, Debates (22 June 2000) p 18104 (per the Hon Dr Michael Wooldridge, Minister for
Health and Aged Care).
7Hain et al, n 4 at p163.
8Tranter M, “A Question of Conﬁdence: An Appraisal of the Operation of the Gene Technology Act 2000” (2003) 20 EPLJ 245
at 259.
9Lawson C, “Risk Assessment in the Regulation of Gene Technology Under the Gene Technology Act 2000 (Cth) and the Gene
Technology Regulations 2001 (Cth)” (2002) 19 EPLJ 195.
10Lawson, n 9 at 195.
11Office of the Gene Technology Regulator, Risk Assessment and Risk Management Plan: Agronomic Assessment and Seed
Increase in Eastern Australia of Transgenic Cotton Expressing cry1Ac and cry2Ab genes from Bacillus thuringiensis – DIR
005/2001 (OGTR, 2001).
12Lawson, n 9 at 208.
13Millstone E, Brunner E and Mayer S, “Beyond Substantial Equivalence” (1999) 401 Nature 525.
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14 The underlying assumption was that there is no difference
between GM crops and their non-GM counterparts. At this time, there was no evidence upon which to
base any conclusions.
Substantial equivalence
The need to benchmark novel products against one of known impact is a requirement of all impact
assessment procedures. It allows meaningful comparisons to be made between one state and another;
in the case of GM crops this means before and after the insertion of a new gene. Since humans have
long grown and eaten traditional food crops, and GM plants are derived from these, the appropriate
benchmark is the original crop plant.
15 The assumption is that if a new GM crop is demonstrated to be
equivalent to the non-GM comparator there should be no increased risk associated with their use. The
issue with this approach to risk assessment is not the use of non- GM crops as a comparator species;
it is with the parameters chosen to establish that the GM crop is equivalent to the comparator species.
Under the model of substantial equivalence, which is the basis of GM crop assessment guidelines
worldwide,
16 risk assessment starts with a comparative analysis of the GM plant with its non-GM
counterpart. The purpose of the comparison is to identify any differences between them. A quantitative
analysis of known toxins, allergens and selected nutrients, anti-nutrients, proteins, fats and
carbohydrates is performed along with a comparison of features such as agronomic performance. This
comparison leads to the plant being classiﬁed as:
17
1. Substantially equivalent: there is no difference between the GM and its non-GM comparator;
2. Substantially equivalent except for the introduced gene: this is the usual ﬁnding with GM
plants, in which case the protein/s produced by the newly inserted gene are tested for
toxicological or allergenicity potential; or
3. Not equivalent: substantial differences identiﬁed, in which case the whole food/plant is further
tested for toxicological or allergenicity concerns.
Once classiﬁed, any identiﬁed differences are then “subjected to a classical evaluation of their
potential toxic, allergenic, or nutritional impacts”.
18 However, if differences are not identiﬁed during
the initial screening, they will not be detected in later stages of the assessment process, which
concentrate on the products of the inserted gene and on conﬁrming that known plant toxins are not
produced in hazardous concentrations.
The detection of unknown toxins or allergens is therefore dependent upon these substances
altering the composition of the few generic plant components that are tested. For example, plant
production of a hazardous protein would need to result in signiﬁcant alteration of the total protein
content for a “red ﬂag to be raised”. Given that a plant species can produce up to 5000 different
constituents,
19 including many toxins,
20 it is imperative that hazard identiﬁcation is conducted using
techniques that are accurate, sensitive and speciﬁc. Comparing components such as total proteins does
not represent an assay of sufficient sensitivity to provide conclusive evidence that there is no
difference in individual protein composition.
21
14World Health Organisation (WHO), Strategies for Assessing the Safety of Foods Produced by Biotechnology (Report of Joint
FAO/WHO Consultation, Geneva, 1991).
15Kuiper HA, Kleter GA, Hub P, Noteborn JM and Kok EJ, “Assessment of the Food Safety Issues Related to Genetically
Modiﬁed Foods” (2001) 27(6) The Plant Journal 503 at 504.
16International Food Biotechnology Committee (IFBC), “Nutritional and Safety Assessments of Foods and Feeds Nutritionally
Improved through Biotechnology” (2004) 3 Comprehensive Reviews in Food Science and Food Safety 1 at 45.
17Kuiper et al, n 15 at 504
18IFBC, n 16 at 45.
19Schubert D, “Sensible Regulations for GM Food Crops” (2005) 23 Nature Biotechnology 785.
20Ames BN, Profet M, Gold LS, “Dietary Pesticides (99.99% all natural)” (1990) 87 Proc Natl Acad Sci USA 7777.
21Corpillo D, Gardini G, Vaira AM, Basso M, Aime S, Accotto GP and Fasano M, “Proteomics as a Tool to Improve
Investigation of Substantial Equivalence in Genetically Modiﬁed Organisms: The Case of a Virus-Resistant Tomato” (2004) 4
Proteomics 193; Millstone et al, n 13 at 525.
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The Gene Technology Act 2000 appoints an independent statutory officer, the gene technology
regulator (the Regulator), to oversee risk assessment, risk management and to make independent
decisions on whether a GM crop is approved for commercial release in Australia. The Regulator
(although supported by the Office of Gene Technology Regulator (OGTR), a Commonwealth
regulatory agency) holds primary responsibility for ensuring that the Act is administered in such a way
that the purpose is achieved.
The object of the Act is
[T]o protect the health and safety of people, and to protect the environment, by identifying risks posed
by or as a result of gene technology, and by managing those risks through regulating certain dealings
with GMOs.
22
The Regulator is therefore responsible for “identifying risks” in order to protect the health and
safety of people and the environment. In this respect hazard identiﬁcation is of vital importance to
ensuring the object of the Act is achieved. Although the Australian regulators do not use the term
“substantial equivalence”, a compositional analysis is used to identify potential toxicity hazards. For
example in the RARMP prepared for Bayer CropSciences InVigor(
23 canola, the Regulator states that
in its evaluation of potential hazards that may result in toxicity to humans and other organisms, a
compositional analysis can “provide evidence of whether any unintended effects have been introduced
into the GM canola lines as a result of the genetic modiﬁcations”.
24 Short-term feeding studies are
documented which provide information on acute toxicity issues but no evidence of chronic toxicity
issues with this crop. The compositional analysis provides evidence to determine whether or not there
are signiﬁcant changes to total plant proteins but provides no evidence concerning altered levels of
individual proteins.
While the stated object of the Act is broad, encompassing “risks posed by, or as a result of gene
technology”, the scope is considerably narrower. For example, references to the health and safety of
people do not include ensuring that GM food is safe, even though any risks are a “result of gene
technology”.
25 The Regulator’s role is largely limited to dealings with GMOs, not their products.
While food safety is often stated as a responsibility of Food Standards Australia and New Zealand
(FSANZ)
26, under the Act the Regulator “has the power to do all things necessary”
27 to perform the
functions set out in s 27 of the Act. As such, the Regulator is “to provide information and advice to
other regulatory agencies about GMOs and GM products”.
28 In this respect, the Regulator has the
power to offer advice to FSANZ with regard to the appropriate methodology to assess GM foods.
The Regulator assesses the risks of releasing GM crops into the environment, but the
consideration of safety is limited to the potential risks that may occur because of such releases. This
includes environmental safety issues, such as risks posed to farm workers through exposure to GM
plant pollen, and to the potential for GM plants to be toxic to other organisms in the environment. In
applications that have been previously been approved for food consumption by FSANZ, the Regulator
considers the outcomes of FSANZ risk assessments in preparation of a RARMP.
29 A crop plant that
has been previously found to be safe for human consumption is considered unlikely to be toxic to the
environment. Therefore if the FSANZ risk assessment does not identify molecular risks it is likely that
the results will also affect the outcome of the OGTR risk assessment procedures.
22Gene Technology Act 2000 (Cth), s 3.
23Office of the Gene Technology Regulator (OGTR), Risk Assessment and Risk Management Plan: DIR 021/2002, Commercial
Release of Genetically Modiﬁed (InVigor® hybrid) Canola (OGTR, 2003).
24OGTR, n 23, p 59.
25Gene Technology Act 2000 (Cth), s 3.
26OGTR, n 23, p 20.
27Gene Technology Act 2000 (Cth), s 28.
28Gene Technology Act 2000 (Cth), s 27(e).
29Gene Technology Regulations 2001 (Cth), s 10(1).
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issues associated with new GM crops or foods derived from new GM crops. An illustration of how
even signiﬁcant changes to plant composition are not detected using this compositional analysis is
provided in the following case study.
Case study: Genetically modiﬁed corn
Monsanto’s Mon810
30 and Synergenta’s Bt11
31 GM insect resistant corn are approved for human
consumption in Australia and are grown commercially in North America, Canada and Argentina.
These crops underwent the “rigorous science-based” health and/or environmental safety assessment
processes of the countries in which they are grown or consumed. In Australia, FSANZ (formerly
Australian and New Zealand Food Authority (ANZFA)) performed both risk assessments, using a
range of criteria in the safety evaluations, including:
characterisation of the transferred genes, analysis of changes at the DNA, protein and whole food levels,
stability of the introduced genes, evaluation of intended and unintended changes and assessment of the
potential allergenicity or toxicity of any newly expressed proteins.
32
The levels of 18 amino acids were also tested and importantly, eight of these (44%) were found to
be present in signiﬁcantly higher concentrations in Mon810 corn compared to the control line. The
comparison was broadened to include both the “literature range” for amino acids in corn and to other
GM corn lines. Based on these comparisons it was concluded that these differences in amino acid
levels were not “considered to represent a biological meaningful difference”.
33 However, ﬁve years
after passing the health and safety assessment procedures of the American Food and Drug Authority
(FDA), and one year after they were approved for consumption in Australia by FSANZ, it was
discovered that Mon810 and Bt11 corn stalks contain 33-97% more lignin than non GM corn.
34 The
indigestibility of lignin has previously led to attempts with GE techniques to reduce its content in
feed
35, yet inadvertently its content has been increased in one of the most important, and widely
planted food crops.
Whilst signiﬁcantly higher lignin content in corn stalks may, or may not, be a toxicity issue, there
are concerns with these ﬁndings. Scientiﬁc understanding of the lignin biosynthetic pathway is
incomplete;
36 however, it is a known product of the shikimic acid pathway, an extremely important
biochemical pathway in plants. An estimated 40% of the dry weight component of plants are products
of this pathway.
37 As far as could be ascertained from the published literature or from either the
OGTR or FSANZ websites there have been no studies investigating whether or not this unintended
effect is also apparent in corn kernels. However, evidence of signiﬁcant differences in amino acid
composition,
38 particularly the aromatic amino acids, tyrosine, phenylalanine and tryptophan, which
are produced by the shikimic acid pathway, suggest potentially altered metabolism in the kernel also.
This is a concern because, as Schubert notes, “components of this same biochemical pathway also
30Australia New Zealand Food Authority (ANZFA), Food derived from insect-protected corn line Mon810: A Safety Assessment
(Technical Report Series Number 5, ANZFA, 2001) available online at http://www.foodstandards.gov.au/_srcﬁles/TR5.pdf
(viewed 15 May 2006).
31Australia New Zealand Food Authority (ANZFA), Food derived from insect-protected, herbicide-tolerant Bt-11 corn: A safety
Assessment (Technical Report series No 10, ANZFA, 2001) available online at http://www.foodstandards.gov.au/_srcﬁles/
TR10.pdf (viewed 15 May 2006).
32ANZFA, n 30, p 3.
33ANZFA, n 30, p 15.
34Saxena D and Stotzky G, “Bt Corn Has a Higher Lignin Content Than Non-Bt Corn” (2001) 88 (9) American J Bot 1704.
35Sewalt VJH, Weiting NW, Blount JW, Jung HC, Masoud SA, Howle PA, Lamb C and Dixon RA, “Reduced Lignin Content
and Altered Lignin Composition in Transgenic Tobacco Down-Regulated in Expression of L-Phenylalanine Ammonia-Lyase or
Cinnamate 4-Hydroxylase” (1997) 115 (1) Plant Physiol 41.
36Kutchan TM, “Predictive Metabolic Engineering in Plants: Still Full of Surprises” (2005) 23 (8) Trends in Biotechnology 381.
37Freese W and Schubert D, “Safety Testing of Genetically Engineered Food” (2004) 21 Biotechnology and Genetic
Engineering Reviews 299.
38ANZFA, n 30, p 15.
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plant-produced insecticide that may cause Parkinson’s disease”.
39 Furthermore, metabolic precursors
to lignin biosynthesis are known to have detrimental effects in mammals. For example, caffeic acid, a
lignin precursor, is known to cause forestomach tumors in male mice and in both male and female
rats.
40
Other direct or indirect effects resulting from the altered lignin content in these GM corn crops
may become evident with further analysis. However, there is no evidence that issues such as these
have been considered by either FSANZ or OGTR.
HAZARD IDENTIFICATION
The Act provides very little guidance on the process of risk assessment and risk management, and the
Regulator has prepared detailed administrative guidelines outlining the approach to be used in the risk
assessment process.
41 The Risk Analysis Framework (RAF) document outlines the principles of risk
analysis developed to protect human health and safety, and the environment, in accordance with s 51
of the Act.
42 Risk analysis is deﬁned in its broad sense as encompassing risk assessment, risk
management and risk communication. Risk assessment is deﬁned as the overall process of hazard
identiﬁcation and risk estimation.
43 The risk estimate is derived from both the “likelihood” and
“consequence” of any identiﬁed hazard and is affected by uncertainty in either of these parameters.
44A
risk assessment matrix is generated, which provides estimates of the level of risk (negligible, low,
moderate or high), which is then used to develop risk management strategies.
The importance of hazard identiﬁcation in the risk assessment process is acknowledged in the
phrase: “hazard identiﬁcation underpins the process of risk assessment”.
45 Likewise, the Regulator
accepts that if hazards are not identiﬁed that they “may pose a major threat to health and the
environment” and commits to the use of a “comprehensive approach” to hazard identiﬁcation to
ensure that the full range of hazards are identiﬁed.
46 The RAF does not prescribe a methodology to be
used in the hazard analysis process, but refers speciﬁcally to investigating hazards posed by:
47
• altered biochemistry;
• altered physiology;
• unintended change in gene expression;
• production of a substance toxic to humans;
• production of a substance allergenic to humans; or
• production of a substance that is toxic to, or causes ill health, or mortality, in non-target
organisms.
The risks analysis approach used by the Regulator is described as employing the use of
quantitative evidence and information, but it is also acknowledged that the approach will not rely on
the use of a quantitative risk assessment.
48 The Regulator asserts that qualitative risk assessment is the
most feasible approach to assess risks because:
49
39Schubert, n 19 at 786.
40McGregor D, “Diets, Food Components and Human Cancer” (1998) 11 Biotherapy 189.
41Peel J, The Precautionary Principle in Practice: Environmental Decision-Making and Scientiﬁc Uncertainty (The Federation
Press, 2005).
42Office of the Gene Technology Regulator (OGTR), Risk Analysis Framework (OGTR, 2005).
43OGTR, n 42, p 18.
44OGTR, n 42, p 18.
45OGTR, n 42, p 35.
46OGTR, n 42, p 35.
47OGTR, n 42, p 37.
48OGTR, n 42, p 28.
49OGTR, n 42, p 25.
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• potential human health and environmental adverse effects are highly varied;
• environmental effects arise within highly complex systems that have many incompletely
understood variables; and
• adverse effects may occur in the long term and are therefore difficult to quantify.
Although it is extremely difficult to quantify complex ecological interactions, rigorous analysis of
plant composition will signiﬁcantly improve the hazard identiﬁcation process, thereby reducing the
potential for negative ecological impacts to occur. As such, it is important that initial hazard
identiﬁcation procedures utilise methods that are unbiased, sensitive and speciﬁc. While compositional
analysis is a quantitative procedure, the decision by the Regulator to use parameters such as whole
proteins and fats to detect changes in plant constituents is highly speculative
50 as there is no evidence
that this method of hazard identiﬁcation provides any scientiﬁcally meaningful data. This severely
undermines claims by the Regulator that information in the risk analysis process is assessed “against
rigorous scientiﬁc standards.”
51
The question of whether the process of genetic engineering poses different potential hazards to
traditional breeding practises underlies the molecular debate. Risk assessment procedures used in
many countries, including Australia, hinge on the assumption that there are no increased risks
associated with the use of biotechnology in plant breeding procedures.
52
Efficacy of genetic engineering techniques
Industry proponents portray GE techniques
53 as a simple extension of traditional breeding practices. A
common argument is that genetic engineering is a precise technology that allows a single
well-characterised gene to be inserted into a new species.
54 The argument rests on the assumption that
inserting one well-characterised gene results in less disruption and therefore less risk than in
traditional breeding techniques. Traditional breeding techniques generally involve the recombination
of thousands of genes between breeding pairs. By comparison, genetic engineering techniques involve
inserting a gene (or genes), often highly modiﬁed using recombinant DNA technology, into the
genome of a plant species. For example, if the desired outcome is herbicide tolerance in a plant, a
gene producing an enzyme that degrades the herbicide is randomly inserted into the plant’s genome.
The genetic engineering process used to introduce foreign DNA into a cell is known as
transformation. In the creation of GM plants there are two main methods of transformation used,
namely:
55
• Microprojectile bombardment: which involves coating microscopic beads of tungsten or gold with
the fragments of DNA constructed for insertion. The beads are then ﬁred, using air pressure, into
a culture of plant cells. The beads penetrate the cell wall and hopefully end up in the nucleus of
the cell were they may be integrated into the cell’s DNA. New plants are then regenerated from
these cells; or
• T-DNA transfer: which involves the use of a soil bacterium that is responsible for causing crown
gall in plants. This bacterium has the ability to penetrate the cell wall and insert sections of its
DNA into its host’s DNA. Scientists have utilised this ability to deliver DNA of interest into new
cells. New plants are regenerated from these cells.
Two recently published studies have demonstrated that both transformation processes lead to
mutations in the plant genome. One study investigated the effects of gene transfer by microprojectile
50Millstone et al, n 13 at 526; Corpillo et al, n 21 at 199.
51OGTR, n 42, p 45.
52IFBC, n 16 at 45.
53Miller HI and Conko G, “Precaution Without Principle” (2001) 19 Nature Biotechnology 302; IFBC, n 16 at 39.
54WHO, n 14 at s 4.2.1.
55Glick BR and Pasternak JJ, Molecular Biotechnology: Principals and Applications of Recombinant DNA (3rd ed, ASM Press,
2003) pp 517-523.
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regions of plant DNA and smaller regions of the transgene had been scrambled during gene
insertion.
56 In the second, research on the effects of the T-DNA transfer system found that the process
results in both small and large-scale deletions and rearrangements of the plant’s genes.
57 The research
concentrated on analysing the whole genome and found both minor and gross alterations. Interestingly,
many of these changes were localised to the area of the insert, but in several GM plants there was
evidence of genome-wide structural change. While the resulting effects on plant metabolism were not
studied, the authors conclude that these results need to be considered when characterising new GM
crops.
58 Both of the GE techniques used to transfer genes into plants can result in extensive mutation,
with unknown effects although the two studies have shown that many mutations are not necessarily
lethal to the plant. Contrary to the stance taken by biotech industry proponents,
59 GM procedures are
not precise and a cursory compositional analysis is not sufficient to demonstrate food and
environmental safety.
It was long thought that genes in higher organisms such as plants and mammals were positioned
randomly in the genome, however recent research demonstrates that DNA structure is more organised
than previously believed. The ﬁrst statistically vigorous analysis of complete genomes reported that
genes are clustered in functional groups in the genome.
60 Many traits require the product of more than
one gene, with genes required for the same trait (function) clustered together on the chromosome and
often transferred between breeding partners in these functional clusters. Their position in the genome
is not altered during breeding practices and the transferred genes are therefore in the same predictable
locations on the chromosome. This is in stark contrast to genetic engineering procedures which:
• insert genes randomly into the genome, their ﬁnal position could be anywhere in the genome of
the cell;
61
• can result in large areas of the plant’s genome being deleted, duplicated or moved to a different
place in the plant genome;
62
• can result in two or more whole copies and also fragments of the transgene being inserted into the
plant’s genome;
63
• can result in insertion of a transgene, or parts of transgene, into a plant gene, which has the
potential to decrease or disrupt expression patterns of the plant’s own genes;
64
• have the potential to increase production of toxins not known to occur in the plant by activating
silent genes or increasing production of toxins not yet identiﬁed in the plant species;
65
• transfer genes into the cell that operate outside the cell’s own regulatory mechanisms and are
therefore always turned on, sometimes in every cell of the plant;
66 and
56Makarevitch I, Svitashev SK, and Somers DA, “Complete Sequence Analysis of Transgene Loci from Plants Transformed via
Microprojectile Bombardment” (2003) 52 Plant Mol Biol 421.
57Forsbach A, Schubert D, Lechtenberg B, Gils M and Schmidt R, “A Comprehensive Characterization of Single-Copy T-DNA
Insertions in the Arabidopsis Thaliana Genome” (2003) 52 Plant Mol Biol 161.
58Forsbach et al, n 57 at 162.
59Miller and Conko, n 53 at 302.
60Hurst LD, Pál C and Lercher MJ, “The Evolutionary Dynamics of Eukaryotic Gene Order” (2004) 5 Nature Reviews Genetics
299.
61Martineau B, The Creation of the FlavrSavr® Tomato and the Birth of Biotech Food (McGraw-Hill, 2001) p 69.
62Takano M, Egawa H, Ikedo J and Wakasa K, “The Structures of Integration Sites in Transgenic Rice” (1997) 11(3) The Plant
Journal 353; Somers DA, Olhoft PM, Makarevitch IF and Svitashev SK “Mechanism(s) of Transgene Locus Formation” in
Laing DH and Skinner DZ (eds) Genetically modiﬁed crops: their development, uses and risks, (Haworth Press, 2004).
63Gasson M and Burke D, “Scientiﬁc Perspectives on Regulating the Safety of Genetically Modiﬁed Foods” (2001) 2 Nature
Reviews Genetics 217.
64Schubert D, “A Different Perspective on GM Food” (2002) 20 Nature Biotechnology 969.
65Schubert, n 64 at 969.
66Schubert, n 19 at 786.
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gene operates in the new cell, but which have the potential to change the expression patterns of
plant genes located near to them on the genome.
67
These issues have lead to recognition that each new GM crop should be evaluated on a case by
case basis as each gene insertion “event” has the potential to result in completely different outcomes.
68
Unintended effects
Another argument of industry proponents is that inserting a gene of known function will reduce the
chance of unintended effects occurring. There are however many examples in the literature illustrating
that insertion of a gene with known function can result in completely unexpected results on plant
metabolism.
69 Several possibilities may explain these results. First, as described previously, the
insertion of genes by GE techniques can lead to unintended mutations of the plant genome, which can
result in altered plant physiology. Given that single point mutations can lead to “complex responses at
the level of the whole organism”,
70 both transformation techniques carry a risk of mutation leading to
unintended effects. Secondly, in the cells of all living organisms, genes are expressed in concert with
many other genes, often with the product of one gene leading to the production of other gene products.
When genes are transferred into a new plant, there is the potential for that gene product to interact
with either plant genes or their products resulting in altered metabolism (pleiotrophic effects). This
potential is impossible to directly predict and requires a more vigorous compositional analysis to
identify than that currently conducted by the Australian regulators.
Industry proponents argue that product development and selection procedures involve processes
that would eliminate the potential for these unknown/unintended effects to reach the marketplace.
71 It
is true that many initial transformants (GM plants) are discarded during selection procedures, eg those
plants that have either gross abnormalities, or other easily tested negative traits such as reduced
agronomic performance. However, as illustrated with the GM corn case study, even large aberrations
to plant metabolism can go undetected in selection procedures and subsequently in risk assessment
procedures.
RISKS: LIKELIHOOD AND CONSEQUENCE
The likelihood of molecular hazard occurring
Very little deﬁnitive quantitative research has investigated the frequency with which unintended
mutations occur during the gene insertion process. Likewise there is little research which examines the
effects of gene insertion on the composition of a broad range of plant produced proteins or secondary
metabolites. This is largely due to the fact that the technology with which to perform sensitive assays
that detect a wide range of plant components has not been readily available. Recently however, there
has been signiﬁcant development in tools and techniques that provide more sensitive, comprehensive
and unbiased analysis of gene expression patterns.
72 Published results generated using these
techniques, suggest that altered plant metabolism is not uncommon.
A technique that uses gas chromatography and mass spectrometry (GC-MS) technologies to
separate and analyze secondary metabolites was reported in 2001, in a study on previously
67Weigel D, Ahn JH, Bla'zquez MA, Borevitz JO, Christensen SK, Fankhauser C, Ferra'ndiz C, Kardailsky I, Malancharuvil EJ,
Neff MM, Nguyen JT, Sato S, Wang Z, Xia Y, Dixon RA, Harrison MJ, Lamb CJ, Yanofsky MF, and Chory J, “Activation
Tagging in Arabidopsis” (2000) 122 Plant Physiology 1003.
68Haselberger AG, “Codex Guidelines for GM Foods Include the Analysis of Unintended Effects” (2003) 21 Nature
Biotechnology 739.
69Haselberger, n 68 at 739; Kuiper et al, n 15 at 516: Both authors provide examples of unintended effects.
70Fiehn O, Kopka J, Dörmann P, Altmann T, Trethewey RN and Willmitzer L, “Metabolite Proﬁling for Plant Functional
Genomics” (2000) 18 Nature Biotechnology 1157.
71IFBC, n 16 at 48.
72Sweetlove LJ, Last RL and Fernie AR, “Predictive Metabolic Engineering: A Goal for Systems Biology” (2003) 132 Plant
Physiology 420.
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73 The tested GM potatoes were genetically modiﬁed to have altered starch
levels. Several ﬁndings were novel, and illustrate that gene insertion results in large changes to gene
expression patterns in plant species. Results presented on 88 metabolites, 61 of which were identiﬁed
in the study, demonstrated that the majority of the tested metabolites had signiﬁcantly altered
metabolism in the GM lines, when compared to the control potatoes. Most of these were due to
changes in starch biochemical pathways, but there were also unexpected aberrations to amino acid
levels and the shikimic acid pathway. Importantly, nine of the 88 metabolites were below the
detectable level in the non-GM potatoes but detected in several of the GM lines. It was noted that;
“[s]ome of these metabolites were observed in all of the transgenic types studied, whereas others were
only present for a certain transgenic manipulation or even for a single transgenic line”.
74 Of concern
was one compound that could not be identiﬁed and was present in extremely high concentrations in
one of the GM lines.
Another relevant paper notes that the use of similar techniques have demonstrated that that there
were substantial differences between a GM and a non-GM potato line.
75 The authors concluded that
the data has “important ramiﬁcations for the potential risk associated with transgenic organisms and
theories of substantial equivalence”. In contrast, similar methods were used to demonstrate that 95%
of the low molecular weight compounds studies in a GM tomato were identical to those produced its
non-GM variety.
76 These studies illustrate that GE techniques are not inherently dangerous, but that
the potential for unintended effects to occur is real and can result in the production of metabolites not
previously produced in the plant.
Protein expression studies using two-dimensional polyacrylamide gel electrophoresis (2-DE)
allow proteins produced in plant cells to be separated by size and electrical charge. Rather than
analyzing total proteins, which is the basis of current hazard identiﬁcation procedures (as outlined
previously), these techniques allow the simultaneous analysis of a large range of speciﬁc proteins, and
their relative amounts, which can then allow a deﬁnitive comparison of protein expression patterns.
77
An advantage of this technique is that the identity of proteins is not required for the initial analysis.
Any differences in protein levels are ﬁrstly identiﬁed using this relatively simple procedure, and any
proteins of interest then extracted and identiﬁed. A problem with this approach is that it only provides
a relative comparison and further tests would be required to quantify any observed differences.
78 The
use of this technique to compare a GM and a non-GM tomato plant demonstrated that the test plant
was substantially equivalent to its comparator line.
79While this illustrated that there were no
unintended effects on the tomatoes plants metabolism, the authors advise that methods such as this are
required to analyze GM plants and to “provide information absolutely crucial for a scientiﬁc solution
of the problem of food safety”.
80
Methods such as GC-MS (also known as metabolic ﬁngerprinting or proﬁling) and protein
expression studies are not currently used to identify hazards in the Australian risk assessment process.
The OGTR, in email correspondence with one of the authors, have made it clear that they consider it
unlikely that hazards will be overlooked in the risk assessment process, stating that:
The Gene Technology Regulator can seek any information deemed necessary for identifying and
assessing risks. Experience from two decades of research on and commercialisation of GM crops, and
73Roessner U, Luedemann A, Brust D, Fiehn O, Linke T, Willmitzer L and Fernie AR, “Metabolic Proﬁling Allows
Comprehensive Phenotyping of Genetically or Environmentally Modiﬁed Plant Systems” (2001) 13 Plant Cell 11.
74Roessner et al, n 73 at 16.
75Urbanczyk-Wochniak E, Luedemann A, Kopka J, Selbig J, Roessner-Tunali U, Willmitzer L and Fernie AR, “Parallel
Analysis of Transcript and Metabolic Proﬁles: A New Approach in Systems Biology” (2003) 4 (10) EMBO Reports 989.
76Noteborn HPJM, Lommen A, Van der Jagt RC and Weseman JM, “Chemical Fingerprinting for the Evaluation of Unintended
Secondary Metabolic Changes in Transgenic Food Crops” (2000) 77 Journal of Biotechnology 103.
77Corpillo et al, n 21 at 193.
78Sweetlove, et al, n 72.
79Corpillo et al, n 21 at 193.
80Corpillo et al, n 21 at 199.
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provides little potential for unexpected adverse outcomes that would not be eliminated in the variety
development process. Therefore it is not expected to make metabolic ﬁngerprinting mandatory unless
there is evidence to suspect that any metabolic changes due to the genetic modiﬁcation are capable of
causing harm to the health and safety of people or harm to the environment.
81
As such, there are no plans by the OGTR to incorporate procedures such as these in the risk
assessment process.
Consequence of unidentiﬁed hazards
Different factors may contribute to the signiﬁcance of adverse consequences which may arise as a
result of hazards not being identiﬁed in the risk assessment process; namely severity, cumulative,
space and reversibility.
82 The very nature of GMOs makes the consequences difficult to predict, but
what is known suggests that if hazards are not identiﬁed the consequences could be of considerable
magnitude.
The severity of any consequence is dependant upon the nature of the risk. In the case of an
increased toxin, the concentration and nature of the toxin contribute to the severity of any
consequence. If the toxin is highly toxic then the consequence could be severe, and if cumulative in
nature then a potential reduction in toxicity would still result in increasing effects over time. While it
is likely that acute toxicity would be detected during the short term feeding tests that are generally
conducted on GM crops prior to commercialisation, this is not the case with toxins that accumulate in
the environment or in living organisms and may result in long-term or cumulative toxicity issues.
Given that commercialisation would result in these crops being cultivated over thousands of acres of
the Australian landscape, there is potential for exposure to be widespread in the Australian
environment. Likewise, the consumption of GM food will result in exposure to signiﬁcant numbers of
the Australian population.
Reversibility is of great importance to determining the consequence of GM crops as the ability to
remove GMOs from the environment once established on a broad scale, can be extremely difficult, as
the experience with Starlink corn illustrates. Starlink corn was approved for feed uses in the United
States in 1998, and was subsequently planted over a relatively small area (<1%) of the United States
corn acreage.
83 It was not approved for human consumption due to allergenicity concerns but was
approved for cultivation for animal feed purposes. In 2000, Starlink corn was discovered by
independent researchers in processed corn products on supermarket shelves in the United States.
84 A
major product recall was conducted and Starlink seed was removed from the market. In 2001 the
Starlink gene was discovered in commercial corn seed and was again discovered in corn products, this
time in the United States and Japan. For this crop to be planted on a relatively small area and yet to
have entered the global food chain illustrates how difficult it is to contain living organisms.
Remediation is not simply a matter of removing the product from the market as cross-contamination
can lead to its persistence in the seed supply.
A further illustration of the pervasiveness of GM crops is the recently discovered contamination
of a Victorian canola shipment with a GM canola line that, although approved by the OGTR, has
never been grown commercially in Australia. It is likely that imported non-GM seed was contaminated
with this GM variety.
85 Given that the commercialisation of GM crops will lead to the potential for
large-scale exposure and that remediation efforts are extremely difficult if post-market hazards are
identiﬁed, it is imperative that a comprehensive investigation of all risk probabilities is conducted
before commercial approval is granted.
81OGTR, Response to questions, email correspondence with Sharon Fox (25 July 2005).
82OGTR, n 42, p 47.
83Lin W, Price GK and Allen EW, “StarLink: Impacts on the U.S. Corn Market and World Trade” (2003) 19 (4) Agribusiness
473.
84Goldman LR and Bucchini L, “Starlink Corn: A Risk Analysis” (2002) 110 (1) Environmental Health Perspectives 5.
85GRAIN, Australia: Farmers Outraged at Canola Contamination available online at http://www.grain.org/research/
contamination.cfm?id=325 (viewed 24 April 2005).
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Whilst the Gene Technology Act 2000 (Cth) and the Gene Technology Regulations 2001 (Cth) provide
little in the way of speciﬁc risk assessment methodologies, the potential risks associated with the use
of gene technologies are acknowledged. Under s 49(2)(b) of the Act, the expected effects, and under
Sch 4, Pt 2.2.2 of the Regulations, unintended effects, including mutation, are to be considered by the
Regulator in the determination of risks to the health and safety of people or to the environment. These
directives, while acknowledged by the Regulator, are not investigated using methods that have the
sensitivity required to provide conclusive evidence that unintended changes to plant metabolism are
identiﬁed.
Furthermore, the crop developer is required under s 7 of the Regulations to provide information
“as comprehensive as existing scientiﬁc knowledge”
86 in their applications to the Regulator. If
relevant data and information is not provided then the applicant must include
• a summary of known existing scientiﬁc evidence relevant to such evaluation; and
• applying that summary – an evaluation of the possible risks based on theoretical approaches, and
research methods, that are generally accepted in the scientiﬁc community.
87
The results of recent experiments demonstrating the extent of mutations induced by
transformation techniques are published in peer-reviewed journals and as such represent scientiﬁc
knowledge that is both available and relevant to the risk assessment of GE crops. Likewise, research
using molecular proﬁling techniques is peer reviewed and scientiﬁcally accepted and relevant to risk
assessment, with several scientists advising that these techniques are important tools for the use of GM
crop risk assessment.
88 There is no evidence that this information has been considered during the
assessments conducted by Australian regulators. This suggests that crop developers present only
evidence that supports their ﬁndings, which in itself is an act of non-compliance under the Act, and
demonstrates substantial bias. Such bias compromises the risk assessment process and should be
addressed by the Regulator.
Improving the Australian risk assessment process can be achieved with relative ease and without
need for amendment to the Act. Mandating the use of techniques such as GC-MS and 2-D gel
electrophoresis in hazard analysis will provide a more comprehensive, sensitive and unbiased analysis
of plant composition. These techniques are used by plant developers to identify genes with
commercial applications and can be used to generate data that would provide a more comprehensive
assessment of a GM plants metabolic state. Such analysis would demonstrate with far more certainty
that a GM-plant is “substantially” equivalent to its non-GM comparator. Utilising these procedures in
the hazard identiﬁcation process will signiﬁcantly reduce the likelihood that GM-crops have any
adverse effects on the Australian public or environment.
CONCLUSION
The evidence presented here raises concerns that GE techniques may produce unintended adverse
results, from theoretical concern, into the realm of the possible and indeed, even the probable. It is
imperative that these issues are addressed by the Regulator, as not doing so is a failure to ensure
human and environmental safety as mandated by the Gene Technology Act 2000 (Cth) and the Gene
Technology Regulations 2001 (Cth). Claims that the Act would provide a comprehensive accountable
regulatory system
89 are overstated, not due to ﬂaws in the Act but as a direct consequence of the
assumptions inherent in the risk assessment procedures. The Act and the Regulations direct the
Regulator to consider the probability of unintended effects and mutation in risk considerations
however, to date there is little evidence that these issues are given due attention in the decision making
process.
86Gene Technology Regulations 2000 (Cth), s 7(3)(a).
87Gene Technology Regulations 2000 (Cth) s 7 (4)(c) and (d).
88Kuiper et al, n 15 at 516; Freese and Schubert, n 37 at 315: Corpillo et al, n 21 at 293.
89Australia, House of Representatives, n 6, p 18104 (per the Hon Dr Michael Wooldridge).
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little change to gene expression in the plant, there is also credible evidence to suggest that genetic
engineering techniques can result in unexpected, potentially hazardous changes in plant composition.
The current use of a broad compositional analysis to investigate unintended changes in plant
metabolism does not represent a rigorous science-based approach to risk assessment. This method of
plant composition analysis is not of sufficient sensitivity to detect even large changes in plant
composition and therefore its use represents a failure on behalf of the Regulator to ensure the
objective of the Act is achieved. Given that hazard identiﬁcation underpins the risk assessment process
it is imperative that the Regulator address this issue to ensure that hazards are identiﬁed and the
objective of the Act is achieved.
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